NCT00131742View on ClinicalTrials.gov

Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

July 31, 2004

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions

Chronic Hepatitis B

Interventions

DRUG

telbivudine

DRUG

lamivudine

Trial Locations (1)

Unknown

Beijing

Sponsors

Lead Sponsor

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Novartis

INDUSTRY